BRCA1 and Hereditary breast and ovarian cancer syndrome: A survey of state chronic disease directors showed that 11/16 considered program integration of CDC Tier 1 genomic applications, such as the use of family history and testing for hereditary breast and ovarian cancer (BRCA1/2 genetic counseling and testing) and Lynch syndrome, to be beneficial to individuals and families in their state [26].